Filters

Phase
    Intervention Type
      Status
        Location:
        LocationClose
        Distance
          Term Search
          You can select from the dropdown list OR enter your own terms to refine the search.

          Last Updated: 01/07/2026

          Need to find the closest trial?
          Sort By Distance
          Save trials for later
          Sign Up
          Not sure about your diagnosis?
          Check Your Symptoms
          2 clinical trials found

            Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

            Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

            Enrollment Status: Recruiting
            Publish Date: September 09, 2025
            Intervention Type: Drug
            Study Phase: Early Phase 1

            Summary: The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

            A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

            A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

            Enrollment Status: Recruiting
            Publish Date: July 03, 2024
            Intervention Type: Drug
            Study Phase: Phase 2/Phase 3

            Summary: The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC

            Showing 1-2 of 2

            Last Updated: 01/07/2026